Man Group PLC Abbott Laboratories Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Man Group PLC holds 309,285 shares of ABT stock, worth $35.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

309,285

Previous 107,769 186.99%

Holding current value

$35.1 Million

Previous $12.2 Million 162.36%

% of portfolio

0.09%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $20.3 Million - $22.7 Million	201,516 Added 186.99%	309,285 $32.1 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $4.8 Million - $5.3 Million	43,829 Added 68.55%	107,769 $12.2 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $8.19 Million - $10 Million	-90,832 Reduced 58.69%	63,940 $7.04 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $10.7 Million - $12.8 Million	-111,988 Reduced 41.98%	154,772 $15 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $101 Million - $113 Million	-1,006,819 Reduced 79.05%	266,760 $29.1 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $37.7 Million - $44.4 Million	389,506 Added 44.06%	1,273,579 $129 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $31.6 Million - $37 Million	332,174 Added 60.19%	884,073 $97.1 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $38.6 Million - $44.7 Million	-399,006 Reduced 41.96%	551,899 $53.4 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $11.5 Million - $13.9 Million	-112,797 Reduced 10.6%	950,905 $103 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $29.4 Million - $35.8 Million	257,430 Added 31.93%	1,063,702 $126 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $14.5 Million - $17.8 Million	-125,819 Reduced 13.5%	806,272 $113 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $66 Million - $73 Million	565,375 Added 154.17%	932,091 $110 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $10.4 Million - $12.2 Million	-98,255 Reduced 21.13%	366,716 $42.5 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $21.8 Million - $25.7 Million	200,443 Added 75.77%	464,971 $55.7 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $1.73 Million - $1.89 Million	-16,488 Reduced 5.87%	264,528 $29 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $6.78 Million - $8.24 Million	73,996 Added 35.74%	281,016 $30.6 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $4.75 Million - $6.08 Million	62,072 Added 42.82%	207,020 $18.9 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $3.03 Million - $4.44 Million	-48,287 Reduced 24.99%	144,948 $11.4 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $3.79 Million - $4.21 Million	48,222 Added 33.25%	193,235 $16.8 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $5.34 Million - $5.79 Million	-65,302 Reduced 31.05%	145,013 $12.1 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $1.22 Million - $1.42 Million	16,713 Added 8.63%	210,315 $17.7 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $153,961 - $186,139	2,325 Added 1.22%	193,602 $15.5 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $14.4 Million - $16.3 Million	-219,385 Reduced 53.42%	191,277 $13.8 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $7.35 Million - $8.87 Million	-120,931 Reduced 22.75%	410,662 $30.1 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $13.7 Million - $15.1 Million	238,198 Added 81.19%	531,593 $32.4 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $16.5 Million - $18.7 Million	293,395 New	293,395 $17.6 Million

Others Institutions Holding ABT

# of Institutions

3,162

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account